Reducing bias in the assessment of treatment effectiveness: Androgen deprivation therapy for prostate cancer

Keyphrases

• Androgen Deprivation Therapy 100%
• Cancer Mortality 16%
• Cancer-specific 16%
• Cancer-specific Survival 16%
• Clinical Decisions 16%
• Confidence Interval 33%
• Hazard Ratio 33%
• High Risk 33%
• Indication Bias 16%
• Instrumental Analysis 16%
• Instrumental Variable Method 50%
• Large Reduction 16%
• Low Risk 16%
• Medicare Database 16%
• Mortality Hazard 16%
• Multivariable Regression 16%
• Overall Mortality 16%
• Prescribing Preference 16%
• Probit Model 16%
• Prostate Cancer 100%
• Prostate Cancer Risk 16%
• Prostate Cancer Screening 16%
• Prostate Tumor 16%
• Protective Effect 16%
• Radical Prostatectomy 16%
• Regression Analysis 16%
• Subgroup Analysis 16%
• Surveillance Epidemiology 16%
• Treatment Assessment 100%
• Treatment Efficacy 100%
• Urologists 50%

Medicine and Dentistry

• Androgen Deprivation Therapy 100%
• Cancer Survival 14%
• Combination Therapy 100%
• Hazard Ratio 28%
• Instrumental Variable Analysis 71%
• Medicare 14%
• Observational Study 14%
• Prostate Cancer 100%
• Prostate Tumor 14%
• Prostatectomy 14%
• Subgroup Analysis 14%
• Surveillance, Epidemiology, and End Results 14%
• Urologist 42%